When Russell Morse Wilder designed the ketogenic diet in 1921 to treat drug-resistant epilepsy in children, he couldn't have known that a century later, researchers would be investigating whether his high-fat, low-carb approach could shield the aging brain from Alzheimer's, Parkinson's, multiple sclerosis, and ALS. A sweeping new review of screening findings from the past 15 years suggests the answer may be yes—not because the diet is a miracle cure, but because it fundamentally changes how our brains access energy when neurodegenerative disease begins to break them down.
The discovery hinges on a simple biological fact: cells typically run on glucose, or sugar. But in people with neurodegenerative diseases, brain cells often lose the ability to use glucose efficiently. The ketogenic diet shifts metabolism away from carbohydrates and toward fat, prompting the liver to produce ketone bodies—acetoacetate, beta-hydroxybutyrate, and acetone—that serve as an alternative brain fuel. These ketones ensure that the protective and repair processes within nerve cells have enough energy to function, even when the normal glucose pathway has failed. This is significant because, across all neurodegenerative diseases—from Alzheimer's to Huntington's to ALS—the underlying problem is the same: mitochondrial dysfunction and inflammation cause nerve cells in the brain and spinal cord to slowly break down and die.
The review, published in the journal Translational Neurodegeneration, went further than simply documenting the diet's energy-switching mechanism. Researchers found that the ketogenic approach appears to activate autophagy, the body's natural cellular cleanup system, which removes damaged components and toxic protein buildup linked to brain decline. It may also reduce oxidative stress and calm the chronic inflammation that contributes to nerve cell damage. Additionally, the diet brings noticeable changes to the gut microbiome, reducing inflammation-associated bacteria while supporting microbes linked to better gut barrier health—a connection that matters because the gut and brain are in constant biochemical conversation, exchanging signals that influence everything from digestion to emotional wellbeing to the fate of degenerative disease itself.
The clinical evidence offers hope. People with Alzheimer's disease experienced improvements in memory, daily functioning, and quality of life without serious adverse effects. Patients with Parkinson's reported higher energy levels, less fatigue, and improved motor function. Positive benefits were also observed across other neurodegenerative conditions. Yet the review authors are careful to note that much of the existing evidence comes from animal studies and small clinical trials, and the diet's real-world promise remains an emerging area of research rather than an established treatment.
There is one practical wrinkle: sticking to the ketogenic diet is hard. Many people find its restrictive nature challenging to maintain long-term, and some withdraw from studies altogether. Still, the findings published over the past 15 years point to something compelling—that by restoring the brain's ability to produce and use energy even as disease damages its usual pathways, a simple shift in what we eat may help protect one of our most precious organs. As research continues, the diet originally designed for childhood epilepsy may yet prove to be a powerful tool in the fight against the neurodegenerative diseases that define aging.